Zyversa Therapeutics Inc

CUSIP 98987D300COMZVSAQ3 2025

Zyversa Therapeutics Inc — Owners — 13D/13G Beneficial Ownership · FBInvestor

13D / 13G Filings

Schedule 13D/13G on record

Beneficial Filers

Distinct reporting persons

Largest Stake

10.0%

Max % of class reported

Institutional Holders

13F filers (latest quarter)

3 filings · latest Aug 14, 2025

#	Filed	Reporting Person	Form	% of Class	Shares	Filing
1	Aug 14, 2025	Armistice Capital, LLC	13G/A	5.0%	416.8K	SEC
2	May 15, 2025	Armistice Capital, LLC	13G	10.0%	285.0K	SEC
3	Nov 14, 2024	Anson Funds Management LP	13G/A	4.9%	54.1K	SEC

Largest reported positions · latest quarter

#	Fund	Shares	Value
1	Guerra Advisors Inc	7	$1